NIH-funded research Career grant

How stress in cells affects immune responses in bowel inflammation

Official title: Endoplasmic Reticulum Stress Controls Innate Lymphoid Cells in Intestinal Inflammation

Funded at Washington University · NIH-11176049 · Data updated 2026-11-12

This study is looking at how certain immune cells in your gut respond to stress and how that might help us find better, personalized treatments for people with inflammatory bowel disease (IBD).

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$166,584
NIH project number5K08DK140612-02
Project IDNIH-11176049 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with inflammatory bowel disease, including conditions like Crohn's disease and ulcerative colitis.

Less likely to help

Patients with bowel inflammation caused by non-autoimmune factors or those without a diagnosis of inflammatory bowel disease may not benefit from this research.

What this research studies

This research investigates the role of innate lymphoid cells in the development and management of inflammatory bowel disease (IBD). The study focuses on how endoplasmic reticulum stress influences these immune cells, which are crucial for gut health. By examining the interactions between immune cells and gut tissue, the research aims to uncover new insights that could lead to personalized treatment strategies for patients with IBD. The approach combines laboratory experiments with clinical insights to better understand the disease mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to more effective and tailored treatments for patients suffering from inflammatory bowel disease.

How similar studies have gone: Previous research has shown promising results in understanding immune cell behavior in bowel diseases, indicating that this approach has potential for success.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Cao, Siyan — Washington University
  • Study coordinator: Cao, Siyan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.